ZA932271B - Compositions for the treatment of infection and disease caused by hepatitis B virus (HBV) - Google Patents

Compositions for the treatment of infection and disease caused by hepatitis B virus (HBV)

Info

Publication number
ZA932271B
ZA932271B ZA932271A ZA932271A ZA932271B ZA 932271 B ZA932271 B ZA 932271B ZA 932271 A ZA932271 A ZA 932271A ZA 932271 A ZA932271 A ZA 932271A ZA 932271 B ZA932271 B ZA 932271B
Authority
ZA
South Africa
Prior art keywords
hbv
hepatitis
virus
infection
compositions
Prior art date
Application number
ZA932271A
Inventor
Dennis W Adair
Kennethh A Smiles
Dannie King
Original Assignee
Oclassen Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oclassen Pharma Inc filed Critical Oclassen Pharma Inc
Publication of ZA932271B publication Critical patent/ZA932271B/en

Links

ZA932271A 1992-04-06 1993-03-30 Compositions for the treatment of infection and disease caused by hepatitis B virus (HBV) ZA932271B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86389092A 1992-04-06 1992-04-06

Publications (1)

Publication Number Publication Date
ZA932271B true ZA932271B (en) 1993-10-18

Family

ID=25342034

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA932271A ZA932271B (en) 1992-04-06 1993-03-30 Compositions for the treatment of infection and disease caused by hepatitis B virus (HBV)

Country Status (3)

Country Link
LT (1) LTIP472A (en)
TW (1) TW217986B (en)
ZA (1) ZA932271B (en)

Also Published As

Publication number Publication date
TW217986B (en) 1993-12-21
LTIP472A (en) 1994-10-25

Similar Documents

Publication Publication Date Title
ITMI931522A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION (HBV)
NO983410D0 (en) Procedures for re-treatment of patients affected by hepatitis C using consensus interferon
HK38293A (en) Hepatitis c virus
EP0594677A4 (en) Antiviral liponucleosides: treatment of hepatitis b
PL324906A1 (en) Vaccines against viral hepatitis of c type
GB8821049D0 (en) Method & composition for treatment & prevention of viral infections
GB2212511B (en) Hepatitis c virus
LTIP863A (en) Aminobenzodiazepines, process for preparing thereof and application for the treatment and prevention of viral diseases
HUT58371A (en) Recombinant virus of marek-disease
DZ1706A1 (en) Hepatitis A vaccine.
IL105169A0 (en) Compositions for the treatment of infection and disease caused by hepatitis b virus(hbv)
ZA913949B (en) Diagnosis and treatment of viral hepatitis
EP0522081A4 (en) Inhibition of disease associated with immunodeficiency virus infection
ZA964094B (en) Compositions and methods for the diagnosis of and vaccination against hepatitis c virus (hcv)
ZA932271B (en) Compositions for the treatment of infection and disease caused by hepatitis B virus (HBV)
EP0452360A4 (en) Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
EP0442744A3 (en) Treatment of viral disease by glycosides
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
PT88420A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING 1- (2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL) -5-ETHYLURACYL AND METHOD FOR TREATING HEPATITIS VIRUS INFECTIONS BY USING SAID COMPOSITIONS
HUT44439A (en) Process for inhibiting the reproduction of viruses and virus infections
GB9425604D0 (en) Peptides effective for diagnsis of hepatitis C infection
IL96667A0 (en) Pharmaceutical compositions containing fibroblast growth factors for the prevention and treatment of viral infections
BG98272A (en) Preparation and method for the treatment of virus hepatitis
IE892593L (en) Treatment of virus diseases
IE892991L (en) Treatment of viral infections